TARS — TARSUS PHARMACEUTICALS INC

Ownership history in Aberdeen Group plc  ·  8 quarters on record

This page tracks every 13F SEC filing in which Aberdeen Group plc reported a position in TARSUS PHARMACEUTICALS INC (TARS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q4)
Avg. % of fund
0.01%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 51,678 -9,919 -16.1% 0.00% $3.1M $59.43
2025 Q2 ADDED 61,597 +9,728 +18.8% 0.00% $2.5M $40.51
2025 Q1 REDUCED 51,869 -41,781 -44.6% 0.01% $2.7M $51.37
2024 Q4 REDUCED 93,650 -8,905 -8.7% 0.01% $5.2M $55.37
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TARS price (monthly, adj. close)

Other funds also holding TARS

As of 2025 Q4 — sorted by position size

Paradigm Biocapital Advisors LP 3Y 5.35% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.81% Deep Track Capital, LP 3Y 4.39% GordonMD Global Investments LP 3.91% MPM BioImpact LLC 3Y 3.08% RTW INVESTMENTS, LP 3Y 7Y 2.74% Frazier Life Sciences Management, L.P. 3Y 1.6% Sands Capital Alternatives, LLC 3Y 1.34% Lisanti Capital Growth, LLC 3Y 7Y 1.25% HighVista Strategies LLC 3Y 7Y 1.13%
← Back to Aberdeen Group plc Holdings